nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CYP3A4—Fingolimod—multiple sclerosis	0.0561	0.246	CbGbCtD
Indapamide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0362	0.158	CbGbCtD
Indapamide—CYP3A4—Triamcinolone—multiple sclerosis	0.0274	0.12	CbGbCtD
Indapamide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0264	0.116	CbGbCtD
Indapamide—CYP3A4—Betamethasone—multiple sclerosis	0.0235	0.103	CbGbCtD
Indapamide—CYP3A4—Prednisolone—multiple sclerosis	0.0232	0.102	CbGbCtD
Indapamide—CYP3A4—Prednisone—multiple sclerosis	0.0219	0.0959	CbGbCtD
Indapamide—CYP3A4—Dexamethasone—multiple sclerosis	0.0137	0.0599	CbGbCtD
Indapamide—KCNE1—nervous system—multiple sclerosis	0.00448	0.0959	CbGeAlD
Indapamide—CA4—nerve—multiple sclerosis	0.00404	0.0865	CbGeAlD
Indapamide—CA7—midbrain—multiple sclerosis	0.00275	0.0588	CbGeAlD
Indapamide—KCNQ1—medulla oblongata—multiple sclerosis	0.00274	0.0586	CbGeAlD
Indapamide—CA7—cerebellum—multiple sclerosis	0.00213	0.0455	CbGeAlD
Indapamide—CA9—cerebellum—multiple sclerosis	0.00187	0.04	CbGeAlD
Indapamide—CA4—brainstem—multiple sclerosis	0.00173	0.0371	CbGeAlD
Indapamide—CA7—brain—multiple sclerosis	0.00173	0.037	CbGeAlD
Indapamide—KCNQ1—brain—multiple sclerosis	0.00157	0.0337	CbGeAlD
Indapamide—CA12—nervous system—multiple sclerosis	0.00147	0.0314	CbGeAlD
Indapamide—CA2—brainstem—multiple sclerosis	0.00144	0.0308	CbGeAlD
Indapamide—CA12—central nervous system—multiple sclerosis	0.00141	0.0302	CbGeAlD
Indapamide—CA2—retina—multiple sclerosis	0.00139	0.0297	CbGeAlD
Indapamide—CA5B—nervous system—multiple sclerosis	0.00132	0.0282	CbGeAlD
Indapamide—CA5B—central nervous system—multiple sclerosis	0.00127	0.0271	CbGeAlD
Indapamide—CA4—medulla oblongata—multiple sclerosis	0.00121	0.0259	CbGeAlD
Indapamide—CA12—brain—multiple sclerosis	0.00112	0.024	CbGeAlD
Indapamide—CA4—midbrain—multiple sclerosis	0.00111	0.0237	CbGeAlD
Indapamide—CA4—spinal cord—multiple sclerosis	0.00108	0.0231	CbGeAlD
Indapamide—CA5B—brain—multiple sclerosis	0.00101	0.0215	CbGeAlD
Indapamide—CA2—medulla oblongata—multiple sclerosis	0.001	0.0215	CbGeAlD
Indapamide—CA2—midbrain—multiple sclerosis	0.000917	0.0196	CbGeAlD
Indapamide—CA4—nervous system—multiple sclerosis	0.000909	0.0195	CbGeAlD
Indapamide—Furosemide—ALB—multiple sclerosis	0.000897	0.624	CrCbGaD
Indapamide—CA2—spinal cord—multiple sclerosis	0.000894	0.0191	CbGeAlD
Indapamide—CA4—central nervous system—multiple sclerosis	0.000875	0.0187	CbGeAlD
Indapamide—CA4—cerebellum—multiple sclerosis	0.000855	0.0183	CbGeAlD
Indapamide—CA2—nervous system—multiple sclerosis	0.000754	0.0161	CbGeAlD
Indapamide—CA2—central nervous system—multiple sclerosis	0.000726	0.0155	CbGeAlD
Indapamide—CA2—cerebellum—multiple sclerosis	0.000709	0.0152	CbGeAlD
Indapamide—CA4—brain—multiple sclerosis	0.000695	0.0149	CbGeAlD
Indapamide—CA2—brain—multiple sclerosis	0.000576	0.0123	CbGeAlD
Indapamide—Oxcarbazepine—ALB—multiple sclerosis	0.00054	0.376	CrCbGaD
Indapamide—Syncope—Dexamethasone—multiple sclerosis	0.000511	0.000706	CcSEcCtD
Indapamide—Arrhythmia—Prednisone—multiple sclerosis	0.000509	0.000704	CcSEcCtD
Indapamide—Infection—Triamcinolone—multiple sclerosis	0.000509	0.000704	CcSEcCtD
Indapamide—Sweating—Methotrexate—multiple sclerosis	0.000509	0.000703	CcSEcCtD
Indapamide—Infection—Methylprednisolone—multiple sclerosis	0.000508	0.000702	CcSEcCtD
Indapamide—Shock—Triamcinolone—multiple sclerosis	0.000504	0.000697	CcSEcCtD
Indapamide—Insomnia—Prednisolone—multiple sclerosis	0.000504	0.000697	CcSEcCtD
Indapamide—Shock—Methylprednisolone—multiple sclerosis	0.000503	0.000696	CcSEcCtD
Indapamide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000502	0.000694	CcSEcCtD
Indapamide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000501	0.000693	CcSEcCtD
Indapamide—Loss of consciousness—Betamethasone—multiple sclerosis	0.000501	0.000692	CcSEcCtD
Indapamide—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000501	0.000692	CcSEcCtD
Indapamide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.0005	0.000692	CcSEcCtD
Indapamide—Paraesthesia—Prednisolone—multiple sclerosis	0.0005	0.000692	CcSEcCtD
Indapamide—Tachycardia—Triamcinolone—multiple sclerosis	0.0005	0.000692	CcSEcCtD
Indapamide—Nausea—Azathioprine—multiple sclerosis	0.000499	0.00069	CcSEcCtD
Indapamide—Tachycardia—Methylprednisolone—multiple sclerosis	0.000499	0.00069	CcSEcCtD
Indapamide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000496	0.000687	CcSEcCtD
Indapamide—Malnutrition—Prednisone—multiple sclerosis	0.000496	0.000686	CcSEcCtD
Indapamide—Erythema—Prednisone—multiple sclerosis	0.000496	0.000686	CcSEcCtD
Indapamide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000495	0.000685	CcSEcCtD
Indapamide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000495	0.000685	CcSEcCtD
Indapamide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000494	0.000684	CcSEcCtD
Indapamide—Asthenia—Mitoxantrone—multiple sclerosis	0.000487	0.000674	CcSEcCtD
Indapamide—CYP3A4—nervous system—multiple sclerosis	0.000486	0.0104	CbGeAlD
Indapamide—Myalgia—Betamethasone—multiple sclerosis	0.000485	0.000671	CcSEcCtD
Indapamide—Myalgia—Dexamethasone—multiple sclerosis	0.000485	0.000671	CcSEcCtD
Indapamide—Anxiety—Dexamethasone—multiple sclerosis	0.000483	0.000668	CcSEcCtD
Indapamide—Anxiety—Betamethasone—multiple sclerosis	0.000483	0.000668	CcSEcCtD
Indapamide—Discomfort—Betamethasone—multiple sclerosis	0.000479	0.000663	CcSEcCtD
Indapamide—Discomfort—Dexamethasone—multiple sclerosis	0.000479	0.000663	CcSEcCtD
Indapamide—Hypotension—Methylprednisolone—multiple sclerosis	0.000478	0.000661	CcSEcCtD
Indapamide—Pain—Prednisolone—multiple sclerosis	0.000476	0.000659	CcSEcCtD
Indapamide—Hepatitis—Methotrexate—multiple sclerosis	0.000476	0.000659	CcSEcCtD
Indapamide—Pharyngitis—Methotrexate—multiple sclerosis	0.000473	0.000654	CcSEcCtD
Indapamide—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00047	0.00065	CcSEcCtD
Indapamide—CYP3A4—central nervous system—multiple sclerosis	0.000468	0.01	CbGeAlD
Indapamide—Vision blurred—Prednisone—multiple sclerosis	0.000467	0.000647	CcSEcCtD
Indapamide—Urethral disorder—Methotrexate—multiple sclerosis	0.000467	0.000646	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000467	0.000646	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000466	0.000644	CcSEcCtD
Indapamide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000465	0.000643	CcSEcCtD
Indapamide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000465	0.000643	CcSEcCtD
Indapamide—Oedema—Betamethasone—multiple sclerosis	0.000465	0.000643	CcSEcCtD
Indapamide—Oedema—Dexamethasone—multiple sclerosis	0.000465	0.000643	CcSEcCtD
Indapamide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000465	0.000643	CcSEcCtD
Indapamide—Insomnia—Triamcinolone—multiple sclerosis	0.000463	0.000641	CcSEcCtD
Indapamide—Insomnia—Methylprednisolone—multiple sclerosis	0.000462	0.000639	CcSEcCtD
Indapamide—Infection—Betamethasone—multiple sclerosis	0.000462	0.000639	CcSEcCtD
Indapamide—Infection—Dexamethasone—multiple sclerosis	0.000462	0.000639	CcSEcCtD
Indapamide—Ill-defined disorder—Prednisone—multiple sclerosis	0.00046	0.000637	CcSEcCtD
Indapamide—Paraesthesia—Triamcinolone—multiple sclerosis	0.00046	0.000636	CcSEcCtD
Indapamide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000459	0.000635	CcSEcCtD
Indapamide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000459	0.000635	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—multiple sclerosis	0.000459	0.000635	CcSEcCtD
Indapamide—Anaemia—Prednisone—multiple sclerosis	0.000458	0.000634	CcSEcCtD
Indapamide—Shock—Dexamethasone—multiple sclerosis	0.000457	0.000633	CcSEcCtD
Indapamide—Shock—Betamethasone—multiple sclerosis	0.000457	0.000633	CcSEcCtD
Indapamide—Dyspnoea—Triamcinolone—multiple sclerosis	0.000457	0.000632	CcSEcCtD
Indapamide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000456	0.000631	CcSEcCtD
Indapamide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000456	0.000631	CcSEcCtD
Indapamide—Agitation—Prednisone—multiple sclerosis	0.000456	0.00063	CcSEcCtD
Indapamide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000455	0.00063	CcSEcCtD
Indapamide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000455	0.00063	CcSEcCtD
Indapamide—Tachycardia—Dexamethasone—multiple sclerosis	0.000454	0.000628	CcSEcCtD
Indapamide—Tachycardia—Betamethasone—multiple sclerosis	0.000454	0.000628	CcSEcCtD
Indapamide—Angioedema—Prednisone—multiple sclerosis	0.000453	0.000627	CcSEcCtD
Indapamide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000451	0.000624	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—multiple sclerosis	0.00045	0.000623	CcSEcCtD
Indapamide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00045	0.000622	CcSEcCtD
Indapamide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000449	0.000622	CcSEcCtD
Indapamide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000449	0.000622	CcSEcCtD
Indapamide—Malaise—Prednisone—multiple sclerosis	0.000447	0.000619	CcSEcCtD
Indapamide—Vertigo—Prednisone—multiple sclerosis	0.000446	0.000616	CcSEcCtD
Indapamide—Syncope—Prednisone—multiple sclerosis	0.000445	0.000615	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—multiple sclerosis	0.000444	0.000614	CcSEcCtD
Indapamide—Anorexia—Dexamethasone—multiple sclerosis	0.000443	0.000613	CcSEcCtD
Indapamide—Anorexia—Betamethasone—multiple sclerosis	0.000443	0.000613	CcSEcCtD
Indapamide—Urticaria—Prednisolone—multiple sclerosis	0.000443	0.000612	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—multiple sclerosis	0.000442	0.000611	CcSEcCtD
Indapamide—Fatigue—Triamcinolone—multiple sclerosis	0.000442	0.000611	CcSEcCtD
Indapamide—Fatigue—Methylprednisolone—multiple sclerosis	0.000441	0.00061	CcSEcCtD
Indapamide—Pain—Triamcinolone—multiple sclerosis	0.000438	0.000606	CcSEcCtD
Indapamide—Loss of consciousness—Prednisone—multiple sclerosis	0.000436	0.000603	CcSEcCtD
Indapamide—Hypotension—Dexamethasone—multiple sclerosis	0.000434	0.000601	CcSEcCtD
Indapamide—Hypotension—Betamethasone—multiple sclerosis	0.000434	0.000601	CcSEcCtD
Indapamide—Vomiting—Mitoxantrone—multiple sclerosis	0.000432	0.000597	CcSEcCtD
Indapamide—Rash—Mitoxantrone—multiple sclerosis	0.000428	0.000592	CcSEcCtD
Indapamide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000428	0.000592	CcSEcCtD
Indapamide—Headache—Mitoxantrone—multiple sclerosis	0.000425	0.000588	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000423	0.000586	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000423	0.000586	CcSEcCtD
Indapamide—Myalgia—Prednisone—multiple sclerosis	0.000422	0.000584	CcSEcCtD
Indapamide—Arthralgia—Prednisone—multiple sclerosis	0.000422	0.000584	CcSEcCtD
Indapamide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000422	0.000584	CcSEcCtD
Indapamide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000421	0.000583	CcSEcCtD
Indapamide—Anxiety—Prednisone—multiple sclerosis	0.000421	0.000582	CcSEcCtD
Indapamide—Insomnia—Betamethasone—multiple sclerosis	0.00042	0.000582	CcSEcCtD
Indapamide—Insomnia—Dexamethasone—multiple sclerosis	0.00042	0.000582	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000419	0.00058	CcSEcCtD
Indapamide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000418	0.000578	CcSEcCtD
Indapamide—Paraesthesia—Betamethasone—multiple sclerosis	0.000417	0.000577	CcSEcCtD
Indapamide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000417	0.000577	CcSEcCtD
Indapamide—Discomfort—Prednisone—multiple sclerosis	0.000417	0.000577	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—multiple sclerosis	0.000415	0.000573	CcSEcCtD
Indapamide—Erythema—Methotrexate—multiple sclerosis	0.000415	0.000573	CcSEcCtD
Indapamide—Hypersensitivity—Prednisolone—multiple sclerosis	0.00041	0.000568	CcSEcCtD
Indapamide—Dyspepsia—Betamethasone—multiple sclerosis	0.000409	0.000566	CcSEcCtD
Indapamide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000409	0.000566	CcSEcCtD
Indapamide—Urticaria—Triamcinolone—multiple sclerosis	0.000407	0.000563	CcSEcCtD
Indapamide—Urticaria—Methylprednisolone—multiple sclerosis	0.000406	0.000562	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—multiple sclerosis	0.000406	0.000561	CcSEcCtD
Indapamide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000405	0.00056	CcSEcCtD
Indapamide—Anaphylactic shock—Prednisone—multiple sclerosis	0.000405	0.00056	CcSEcCtD
Indapamide—Oedema—Prednisone—multiple sclerosis	0.000405	0.00056	CcSEcCtD
Indapamide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000404	0.000559	CcSEcCtD
Indapamide—Decreased appetite—Betamethasone—multiple sclerosis	0.000404	0.000559	CcSEcCtD
Indapamide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000404	0.000559	CcSEcCtD
Indapamide—Nausea—Mitoxantrone—multiple sclerosis	0.000403	0.000558	CcSEcCtD
Indapamide—Infection—Prednisone—multiple sclerosis	0.000402	0.000556	CcSEcCtD
Indapamide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000401	0.000555	CcSEcCtD
Indapamide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000401	0.000555	CcSEcCtD
Indapamide—Back pain—Methotrexate—multiple sclerosis	0.000401	0.000555	CcSEcCtD
Indapamide—Fatigue—Dexamethasone—multiple sclerosis	0.000401	0.000554	CcSEcCtD
Indapamide—Fatigue—Betamethasone—multiple sclerosis	0.000401	0.000554	CcSEcCtD
Indapamide—Shock—Prednisone—multiple sclerosis	0.000398	0.000551	CcSEcCtD
Indapamide—Pain—Dexamethasone—multiple sclerosis	0.000397	0.00055	CcSEcCtD
Indapamide—Pain—Betamethasone—multiple sclerosis	0.000397	0.00055	CcSEcCtD
Indapamide—Nervous system disorder—Prednisone—multiple sclerosis	0.000397	0.000549	CcSEcCtD
Indapamide—Tachycardia—Prednisone—multiple sclerosis	0.000395	0.000546	CcSEcCtD
Indapamide—Skin disorder—Prednisone—multiple sclerosis	0.000393	0.000544	CcSEcCtD
Indapamide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000391	0.000541	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—multiple sclerosis	0.000391	0.00054	CcSEcCtD
Indapamide—Anorexia—Prednisone—multiple sclerosis	0.000386	0.000534	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000385	0.000532	CcSEcCtD
Indapamide—Anaemia—Methotrexate—multiple sclerosis	0.000383	0.00053	CcSEcCtD
Indapamide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000383	0.00053	CcSEcCtD
Indapamide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000383	0.00053	CcSEcCtD
Indapamide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00038	0.000526	CcSEcCtD
Indapamide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00038	0.000526	CcSEcCtD
Indapamide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000377	0.000522	CcSEcCtD
Indapamide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000377	0.000521	CcSEcCtD
Indapamide—Malaise—Methotrexate—multiple sclerosis	0.000374	0.000517	CcSEcCtD
Indapamide—Vertigo—Methotrexate—multiple sclerosis	0.000372	0.000515	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—multiple sclerosis	0.000371	0.000513	CcSEcCtD
Indapamide—Urticaria—Dexamethasone—multiple sclerosis	0.000369	0.000511	CcSEcCtD
Indapamide—Urticaria—Betamethasone—multiple sclerosis	0.000369	0.000511	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000369	0.00051	CcSEcCtD
Indapamide—Dizziness—Prednisolone—multiple sclerosis	0.000368	0.00051	CcSEcCtD
Indapamide—Asthenia—Triamcinolone—multiple sclerosis	0.000368	0.000508	CcSEcCtD
Indapamide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000367	0.000508	CcSEcCtD
Indapamide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000367	0.000508	CcSEcCtD
Indapamide—Abdominal pain—Betamethasone—multiple sclerosis	0.000367	0.000508	CcSEcCtD
Indapamide—Body temperature increased—Betamethasone—multiple sclerosis	0.000367	0.000508	CcSEcCtD
Indapamide—Asthenia—Methylprednisolone—multiple sclerosis	0.000367	0.000507	CcSEcCtD
Indapamide—Insomnia—Prednisone—multiple sclerosis	0.000366	0.000506	CcSEcCtD
Indapamide—Paraesthesia—Prednisone—multiple sclerosis	0.000363	0.000503	CcSEcCtD
Indapamide—Pruritus—Triamcinolone—multiple sclerosis	0.000362	0.000501	CcSEcCtD
Indapamide—Cough—Methotrexate—multiple sclerosis	0.000362	0.0005	CcSEcCtD
Indapamide—Pruritus—Methylprednisolone—multiple sclerosis	0.000362	0.0005	CcSEcCtD
Indapamide—Dyspepsia—Prednisone—multiple sclerosis	0.000356	0.000493	CcSEcCtD
Indapamide—Chest pain—Methotrexate—multiple sclerosis	0.000353	0.000488	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—multiple sclerosis	0.000353	0.000488	CcSEcCtD
Indapamide—Myalgia—Methotrexate—multiple sclerosis	0.000353	0.000488	CcSEcCtD
Indapamide—Decreased appetite—Prednisone—multiple sclerosis	0.000352	0.000487	CcSEcCtD
Indapamide—Rash—Prednisolone—multiple sclerosis	0.000351	0.000486	CcSEcCtD
Indapamide—Dermatitis—Prednisolone—multiple sclerosis	0.000351	0.000485	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00035	0.000485	CcSEcCtD
Indapamide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00035	0.000484	CcSEcCtD
Indapamide—Fatigue—Prednisone—multiple sclerosis	0.000349	0.000483	CcSEcCtD
Indapamide—Headache—Prednisolone—multiple sclerosis	0.000349	0.000483	CcSEcCtD
Indapamide—Discomfort—Methotrexate—multiple sclerosis	0.000349	0.000482	CcSEcCtD
Indapamide—Constipation—Prednisone—multiple sclerosis	0.000346	0.000479	CcSEcCtD
Indapamide—Dizziness—Triamcinolone—multiple sclerosis	0.000339	0.000469	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000338	0.000468	CcSEcCtD
Indapamide—Dizziness—Methylprednisolone—multiple sclerosis	0.000338	0.000468	CcSEcCtD
Indapamide—Infection—Methotrexate—multiple sclerosis	0.000336	0.000465	CcSEcCtD
Indapamide—Feeling abnormal—Prednisone—multiple sclerosis	0.000334	0.000461	CcSEcCtD
Indapamide—Asthenia—Dexamethasone—multiple sclerosis	0.000333	0.000461	CcSEcCtD
Indapamide—Asthenia—Betamethasone—multiple sclerosis	0.000333	0.000461	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000332	0.000459	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000331	0.000458	CcSEcCtD
Indapamide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000331	0.000458	CcSEcCtD
Indapamide—Nausea—Prednisolone—multiple sclerosis	0.000331	0.000458	CcSEcCtD
Indapamide—Pruritus—Betamethasone—multiple sclerosis	0.000329	0.000455	CcSEcCtD
Indapamide—Pruritus—Dexamethasone—multiple sclerosis	0.000329	0.000455	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—multiple sclerosis	0.000329	0.000455	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000327	0.000452	CcSEcCtD
Indapamide—Vomiting—Triamcinolone—multiple sclerosis	0.000326	0.000451	CcSEcCtD
Indapamide—Vomiting—Methylprednisolone—multiple sclerosis	0.000325	0.00045	CcSEcCtD
Indapamide—Rash—Triamcinolone—multiple sclerosis	0.000323	0.000447	CcSEcCtD
Indapamide—Dermatitis—Triamcinolone—multiple sclerosis	0.000323	0.000446	CcSEcCtD
Indapamide—Anorexia—Methotrexate—multiple sclerosis	0.000322	0.000446	CcSEcCtD
Indapamide—Rash—Methylprednisolone—multiple sclerosis	0.000322	0.000446	CcSEcCtD
Indapamide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000322	0.000445	CcSEcCtD
Indapamide—Urticaria—Prednisone—multiple sclerosis	0.000322	0.000445	CcSEcCtD
Indapamide—Headache—Triamcinolone—multiple sclerosis	0.000321	0.000444	CcSEcCtD
Indapamide—Headache—Methylprednisolone—multiple sclerosis	0.00032	0.000443	CcSEcCtD
Indapamide—Body temperature increased—Prednisone—multiple sclerosis	0.00032	0.000443	CcSEcCtD
Indapamide—Abdominal pain—Prednisone—multiple sclerosis	0.00032	0.000443	CcSEcCtD
Indapamide—Diarrhoea—Betamethasone—multiple sclerosis	0.000318	0.00044	CcSEcCtD
Indapamide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000318	0.00044	CcSEcCtD
Indapamide—Hypotension—Methotrexate—multiple sclerosis	0.000316	0.000437	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000308	0.000426	CcSEcCtD
Indapamide—Dizziness—Betamethasone—multiple sclerosis	0.000307	0.000425	CcSEcCtD
Indapamide—Dizziness—Dexamethasone—multiple sclerosis	0.000307	0.000425	CcSEcCtD
Indapamide—Insomnia—Methotrexate—multiple sclerosis	0.000306	0.000423	CcSEcCtD
Indapamide—Nausea—Triamcinolone—multiple sclerosis	0.000304	0.000421	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—multiple sclerosis	0.000304	0.00042	CcSEcCtD
Indapamide—Nausea—Methylprednisolone—multiple sclerosis	0.000304	0.00042	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—multiple sclerosis	0.000302	0.000417	CcSEcCtD
Indapamide—Somnolence—Methotrexate—multiple sclerosis	0.000301	0.000416	CcSEcCtD
Indapamide—Hypersensitivity—Prednisone—multiple sclerosis	0.000298	0.000413	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—multiple sclerosis	0.000298	0.000412	CcSEcCtD
Indapamide—Vomiting—Betamethasone—multiple sclerosis	0.000296	0.000409	CcSEcCtD
Indapamide—Vomiting—Dexamethasone—multiple sclerosis	0.000296	0.000409	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—multiple sclerosis	0.000294	0.000407	CcSEcCtD
Indapamide—Rash—Dexamethasone—multiple sclerosis	0.000293	0.000405	CcSEcCtD
Indapamide—Rash—Betamethasone—multiple sclerosis	0.000293	0.000405	CcSEcCtD
Indapamide—Dermatitis—Betamethasone—multiple sclerosis	0.000293	0.000405	CcSEcCtD
Indapamide—Dermatitis—Dexamethasone—multiple sclerosis	0.000293	0.000405	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000292	0.000404	CcSEcCtD
Indapamide—Fatigue—Methotrexate—multiple sclerosis	0.000292	0.000403	CcSEcCtD
Indapamide—Headache—Betamethasone—multiple sclerosis	0.000291	0.000403	CcSEcCtD
Indapamide—Headache—Dexamethasone—multiple sclerosis	0.000291	0.000403	CcSEcCtD
Indapamide—Asthenia—Prednisone—multiple sclerosis	0.00029	0.000402	CcSEcCtD
Indapamide—Pain—Methotrexate—multiple sclerosis	0.000289	0.0004	CcSEcCtD
Indapamide—Pruritus—Prednisone—multiple sclerosis	0.000286	0.000396	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000279	0.000386	CcSEcCtD
Indapamide—Diarrhoea—Prednisone—multiple sclerosis	0.000277	0.000383	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000277	0.000383	CcSEcCtD
Indapamide—Nausea—Betamethasone—multiple sclerosis	0.000276	0.000382	CcSEcCtD
Indapamide—Nausea—Dexamethasone—multiple sclerosis	0.000276	0.000382	CcSEcCtD
Indapamide—Urticaria—Methotrexate—multiple sclerosis	0.000269	0.000372	CcSEcCtD
Indapamide—Dizziness—Prednisone—multiple sclerosis	0.000268	0.00037	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—multiple sclerosis	0.000267	0.00037	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—multiple sclerosis	0.000267	0.00037	CcSEcCtD
Indapamide—Vomiting—Prednisone—multiple sclerosis	0.000257	0.000356	CcSEcCtD
Indapamide—Rash—Prednisone—multiple sclerosis	0.000255	0.000353	CcSEcCtD
Indapamide—Dermatitis—Prednisone—multiple sclerosis	0.000255	0.000353	CcSEcCtD
Indapamide—Headache—Prednisone—multiple sclerosis	0.000254	0.000351	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—multiple sclerosis	0.000249	0.000345	CcSEcCtD
Indapamide—Asthenia—Methotrexate—multiple sclerosis	0.000243	0.000336	CcSEcCtD
Indapamide—Nausea—Prednisone—multiple sclerosis	0.00024	0.000333	CcSEcCtD
Indapamide—Pruritus—Methotrexate—multiple sclerosis	0.000239	0.000331	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—multiple sclerosis	0.000231	0.00032	CcSEcCtD
Indapamide—Dizziness—Methotrexate—multiple sclerosis	0.000224	0.000309	CcSEcCtD
Indapamide—Vomiting—Methotrexate—multiple sclerosis	0.000215	0.000298	CcSEcCtD
Indapamide—Rash—Methotrexate—multiple sclerosis	0.000213	0.000295	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—multiple sclerosis	0.000213	0.000295	CcSEcCtD
Indapamide—Headache—Methotrexate—multiple sclerosis	0.000212	0.000293	CcSEcCtD
Indapamide—Nausea—Methotrexate—multiple sclerosis	0.000201	0.000278	CcSEcCtD
Indapamide—KCNQ1—Voltage gated Potassium channels—KCNA3—multiple sclerosis	0.000105	0.192	CbGpPWpGaD
Indapamide—KCNQ1—Potassium Channels—KCNA3—multiple sclerosis	5.4e-05	0.0985	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	4.95e-05	0.0903	CbGpPWpGaD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	2.56e-05	0.0467	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—KCNA3—multiple sclerosis	2.36e-05	0.043	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	2.06e-05	0.0375	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	1.56e-05	0.0284	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	1.15e-05	0.0209	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.68e-06	0.0158	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	8.06e-06	0.0147	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	7.7e-06	0.014	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—BCHE—multiple sclerosis	6.61e-06	0.0121	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	6.36e-06	0.0116	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	6.36e-06	0.0116	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.06e-06	0.0111	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.82e-06	0.0106	CbGpPWpGaD
Indapamide—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	5.63e-06	0.0103	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SRM—multiple sclerosis	4.5e-06	0.0082	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.41e-06	0.00804	CbGpPWpGaD
Indapamide—CA7—Metabolism—SRM—multiple sclerosis	4.2e-06	0.00766	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SRM—multiple sclerosis	4.2e-06	0.00766	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	4.04e-06	0.00736	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	4.04e-06	0.00736	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.04e-06	0.00736	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	3.98e-06	0.00727	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	3.98e-06	0.00727	CbGpPWpGaD
Indapamide—CA12—Metabolism—SRM—multiple sclerosis	3.89e-06	0.0071	CbGpPWpGaD
Indapamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	3.62e-06	0.00661	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.49e-06	0.00636	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	3.27e-06	0.00597	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	3.27e-06	0.00597	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP27B1—multiple sclerosis	3.17e-06	0.00578	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP24A1—multiple sclerosis	3.17e-06	0.00578	CbGpPWpGaD
Indapamide—CA4—Metabolism—SRM—multiple sclerosis	3.1e-06	0.00566	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.08e-06	0.00562	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—IFNB1—multiple sclerosis	3.02e-06	0.00551	CbGpPWpGaD
Indapamide—CA2—Metabolism—SRM—multiple sclerosis	2.97e-06	0.00543	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP24A1—multiple sclerosis	2.96e-06	0.0054	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP27B1—multiple sclerosis	2.96e-06	0.0054	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP24A1—multiple sclerosis	2.96e-06	0.0054	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP27B1—multiple sclerosis	2.96e-06	0.0054	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.93e-06	0.00534	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GPC5—multiple sclerosis	2.9e-06	0.00529	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP27B1—multiple sclerosis	2.74e-06	0.005	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP24A1—multiple sclerosis	2.74e-06	0.005	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GPC5—multiple sclerosis	2.71e-06	0.00494	CbGpPWpGaD
Indapamide—CA7—Metabolism—GPC5—multiple sclerosis	2.71e-06	0.00494	CbGpPWpGaD
Indapamide—CA9—Metabolism—SRM—multiple sclerosis	2.51e-06	0.00457	CbGpPWpGaD
Indapamide—CA12—Metabolism—GPC5—multiple sclerosis	2.51e-06	0.00457	CbGpPWpGaD
Indapamide—CA5A—Metabolism—RRM1—multiple sclerosis	2.4e-06	0.00438	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.36e-06	0.00431	CbGpPWpGaD
Indapamide—CA7—Metabolism—RRM1—multiple sclerosis	2.24e-06	0.00409	CbGpPWpGaD
Indapamide—CA5B—Metabolism—RRM1—multiple sclerosis	2.24e-06	0.00409	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP27B1—multiple sclerosis	2.19e-06	0.00399	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP24A1—multiple sclerosis	2.19e-06	0.00399	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.18e-06	0.00398	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP24A1—multiple sclerosis	2.1e-06	0.00382	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP27B1—multiple sclerosis	2.1e-06	0.00382	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	2.08e-06	0.0038	CbGpPWpGaD
Indapamide—CA12—Metabolism—RRM1—multiple sclerosis	2.08e-06	0.00379	CbGpPWpGaD
Indapamide—CA4—Metabolism—GPC5—multiple sclerosis	2e-06	0.00365	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—MAPK1—multiple sclerosis	1.93e-06	0.00352	CbGpPWpGaD
Indapamide—CA2—Metabolism—GPC5—multiple sclerosis	1.92e-06	0.0035	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP24A1—multiple sclerosis	1.77e-06	0.00322	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP27B1—multiple sclerosis	1.77e-06	0.00322	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.74e-06	0.00317	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.74e-06	0.00317	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.71e-06	0.00313	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.71e-06	0.00313	CbGpPWpGaD
Indapamide—CA4—Metabolism—RRM1—multiple sclerosis	1.66e-06	0.00302	CbGpPWpGaD
Indapamide—CA9—Metabolism—GPC5—multiple sclerosis	1.62e-06	0.00295	CbGpPWpGaD
Indapamide—CA2—Metabolism—RRM1—multiple sclerosis	1.59e-06	0.0029	CbGpPWpGaD
Indapamide—CA5A—Metabolism—BCHE—multiple sclerosis	1.38e-06	0.00252	CbGpPWpGaD
Indapamide—CA9—Metabolism—RRM1—multiple sclerosis	1.34e-06	0.00244	CbGpPWpGaD
Indapamide—CA7—Metabolism—BCHE—multiple sclerosis	1.29e-06	0.00235	CbGpPWpGaD
Indapamide—CA5B—Metabolism—BCHE—multiple sclerosis	1.29e-06	0.00235	CbGpPWpGaD
Indapamide—CA12—Metabolism—BCHE—multiple sclerosis	1.19e-06	0.00218	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.11e-06	0.00202	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—STAT3—multiple sclerosis	1.03e-06	0.00187	CbGpPWpGaD
Indapamide—CA4—Metabolism—BCHE—multiple sclerosis	9.52e-07	0.00174	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MAPK1—multiple sclerosis	9.33e-07	0.0017	CbGpPWpGaD
Indapamide—CA2—Metabolism—BCHE—multiple sclerosis	9.12e-07	0.00166	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.08e-07	0.00166	CbGpPWpGaD
Indapamide—CA5A—Metabolism—APOE—multiple sclerosis	8.3e-07	0.00151	CbGpPWpGaD
Indapamide—CA7—Metabolism—APOE—multiple sclerosis	7.75e-07	0.00141	CbGpPWpGaD
Indapamide—CA5B—Metabolism—APOE—multiple sclerosis	7.75e-07	0.00141	CbGpPWpGaD
Indapamide—CA9—Metabolism—BCHE—multiple sclerosis	7.69e-07	0.0014	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.36e-07	0.00134	CbGpPWpGaD
Indapamide—CA12—Metabolism—APOE—multiple sclerosis	7.18e-07	0.00131	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—IL6—multiple sclerosis	7.17e-07	0.00131	CbGpPWpGaD
Indapamide—CA5A—Metabolism—POMC—multiple sclerosis	7.13e-07	0.0013	CbGpPWpGaD
Indapamide—CA5B—Metabolism—POMC—multiple sclerosis	6.66e-07	0.00121	CbGpPWpGaD
Indapamide—CA7—Metabolism—POMC—multiple sclerosis	6.66e-07	0.00121	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ALB—multiple sclerosis	6.5e-07	0.00119	CbGpPWpGaD
Indapamide—CA12—Metabolism—POMC—multiple sclerosis	6.17e-07	0.00112	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALB—multiple sclerosis	6.07e-07	0.00111	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALB—multiple sclerosis	6.07e-07	0.00111	CbGpPWpGaD
Indapamide—CA4—Metabolism—APOE—multiple sclerosis	5.72e-07	0.00104	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALB—multiple sclerosis	5.62e-07	0.00103	CbGpPWpGaD
Indapamide—CA2—Metabolism—APOE—multiple sclerosis	5.49e-07	0.001	CbGpPWpGaD
Indapamide—CA4—Metabolism—POMC—multiple sclerosis	4.92e-07	0.000897	CbGpPWpGaD
Indapamide—CA2—Metabolism—POMC—multiple sclerosis	4.71e-07	0.00086	CbGpPWpGaD
Indapamide—CA9—Metabolism—APOE—multiple sclerosis	4.63e-07	0.000844	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALB—multiple sclerosis	4.48e-07	0.000818	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALB—multiple sclerosis	4.3e-07	0.000784	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SRM—multiple sclerosis	4.22e-07	0.00077	CbGpPWpGaD
Indapamide—CA9—Metabolism—POMC—multiple sclerosis	3.97e-07	0.000725	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.91e-07	0.000713	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALB—multiple sclerosis	3.62e-07	0.000661	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.97e-07	0.000542	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.97e-07	0.000542	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.72e-07	0.000496	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.25e-07	0.000411	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.29e-07	0.000236	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—APOE—multiple sclerosis	7.79e-08	0.000142	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—POMC—multiple sclerosis	6.69e-08	0.000122	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALB—multiple sclerosis	6.1e-08	0.000111	CbGpPWpGaD
